Ambergen
Promotion FPO

Products

Proteomic Analysis
  • Cell-free expressed antigens
  • Photocleavable labeling reagents
  • tRNA labeling reagents
  • LIVE-PRO biomarker discovery
  • PC-ICAT
Genomic Analysis
  • Photocleavable phosphoramidites
  • Photocleavable-Fluoro-NTPs
  • PC-DNA-peptide hybridization tags
  • MASSIVE-PRO Mutation Scanning
Signature Cancer Assays
  • CRC-Recurrence Signature
Genetic Disorder Test
See All Products >

Technology

AMB-GCS
  • Genomic Cancer Signature Discovery
LIVE-PRO
  • A new approach to proteomics and biomarker discovery
MASSIVE-PRO
  • High-sensitivity mass spec-based mutation scanning
PC-Linkers
  • Rapid photocleavable compounds for biotechnology
T2 ELISA
  • A new form of ELISA based on proprietary cell-free expressed antigens
See All Technologies >

Ambergen News

September 2008

Ambergen receives US patent #7,423,122 on its T2 ELISA technology

July 2008

Paper published in Analytical Biochemistry on AmberGen's novel technology "Photocleavage Based Affinity Purification and Printing of Cell-Free Expressed Proteins: Application to Proteome Microarrays"

July 2008

NIH-NCI announces $1.2 million Phase II SBIR Award for AmberGen to develop and commercialize a high sensitivity drug resistance assay for CML patients

More News >

How to Order

Please contact sales at
sales@ambergen.com

Custom Products

Ambergen's laboratory and production facilities can help bring your research to life. Learn More >

Product Licensing

Use of Ambergen products for research, product line integration, and bundling. Learn More >